Kestra Medical Technologies Q1 Net Loss Widens, Revenue Rises; Lifts 2027 Outlook

04:23 PM EDT, 09/14/2026 (MT Newswires) -- Kestra Medical Technologies (KMTS) reported a fiscal Q1 net loss late Monday of $0.75 per diluted share, widening from a loss of $0.50 a year earlier. Analysts polled by FactSet expected a loss of $0.62. Revenue for the quarter ended July 31 was $31.0 million, up from $19.3 million a year earlier. Analysts expected $29 million. For fiscal 2027, Kestra now expects revenue of $141 million, compared with its previous guidance of $137 million. Analysts expect $137 million.